Catalyst

Slingshot members are tracking this event:

European Commission Grants Another Year of Conditional Approval to PTC Therapeutics' (PTCT) Translarna in Nonsense Mutation Duchenne Muscular Dystrophy

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
PTCT

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 09, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords European Commission, Conditional Approval, Translarna, Nonsense Mutation Duchenne Muscular Dystrophy